• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Platinum cancer drugs tied to hearing loss in kids

Posted on: Monday, 9 January 2006, 18:17 CST

By David Douglas

NEW YORK (Reuters Health) - Hearing loss appears to be a significant and under-reported side effect of platinum-based drugs used to treat a variety of childhood cancers, according to researchers.

As senior investigator Dr. Edward A. Neuwelt told Reuters Health, so-called "mild" hearing loss "has major impact on academic and social development in kids, is very common after platinum chemotherapy, and may be prevented using" drugs called "thiol oto-protectants" that do not compromise the anti-cancer effects of the chemotherapy.

In the Journal of Clinical Oncology, Neuwelt of Oregon Health and Science University, Portland and colleagues report on their study of 67 children and young adults treated with platinum-based chemotherapy.

Decreased hearing in both ears was noted in 61 percent of children. Children treated for bone and nerve cancers called osteosarcoma, neurosarcoma, and medulloblastoma had higher rates of hearing loss and loss was more severe. Typically, it took just over four months for the hearing loss to occur.

"Hearing loss at frequencies above 2000 Hz is highly significant in young children," the researchers write. "To properly build their language foundation, children must be able to hear all the sounds of speech."

They also note that various agents, including sodium thiosulfate and thiol drugs are being studied for potential protection against treatment-related ear damage.

SOURCE: Journal of Clinical Oncology, December 2005.

Source: REUTERS

More News in this Category